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Background: Head and neck cancers are often diagnosed at a late stage, thus resulting in a generally poor26
prognosis. This is partly attributable to patients’ hesitancy in seeking treatment. However, the length and causes27
of these patient delays remain relatively unknown.28
Material and methods: We included all new head and neck cancer patients treated at our tertiary care center29
between 2016 and 2017. Using a patient questionnaire, we collected data on patients´ symptoms and other30
factors related to seeking medical care, and recorded both patient- and primary health care--related delays. We31
then compared the data collected from these patients to patient and tumor characteristics collected from hospital32
records, and analyzed various causes for delay before a specialist consultation to the Department of33
Otorhinolaryngology – Head and Neck Surgery.34
Results: Among the patients (n = 142) in our study, the median patient delay was 35 d with 73% of patients35
seeking medical care within 3 months. In comparison, the median primary health-care delay was 20 d. Certain36
symptoms influenced patient delay. Hoarseness and breathing difficulties correlated with longer patient delay37
while patients with a lump on the neck had a shorter delay. Patient delay was associated with certain tumor-38
related factors such as the tumor site and the presence of regional metastases, which resulted in shorter patient39
delay. None of the patient-related factors appeared to impact delay. Important factors influencing primary health-40
care delay included the initial location visited and whether any follow-up visit was scheduled or not.41
Conclusions: Although most patients sought medical advice without a major delay and were adequately referred,42
we found that long delays existed. Raising awareness of the symptoms of head and neck cancer among general43
population and health-care providers is probably the best way to get patients to curative treatment without delay.44
2Introduction45
Head and neck cancer (HNC) is the seventh most common non-skin cancer worldwide with an estimated 700,000 new46
cases diagnosed annually [1]. Survival of head and neck cancer (HNC) remains low despite advanced treatment47
modalities [1], whereby the stage of disease markedly affects survival [3]. Many studies support the notion that delays48
affect survival [2-6]. The underlying causes are multifactorial and require evaluation. General practitioners (GP) play a49
crucial role in symptom recognition and cancer diagnostics [7]. Further, patients’ response to bodily sensations and50
symptoms vary, thus affecting their search for medical care [8]. Patients with early stage disease can often be managed51
with single modality treatment, with fewer recurrences in follow-up and better overall survival compared with advanced52
stage disease.53
54
Olesen et al. [9] defines different time intervals from the first symptom until treatment initiation. Delay before treatment55
may be divided into patient- and health care--related delay. A health care--related delay may be further divided into56
primary health care (PHC) delay and a specialist health care delay. PHC includes visits to a GP, a dentist, a private57
otorhinolaryngologist or other specialist, or to a hospital emergency department. In our study, specialist health care58
delay includes the time interval from the first referral to specialist-care Department of Otorhinolaryngology – Head and59
Neck Surgery (ENT department) until the start of treatment. Olesen et al. [9]  called this period “Delay in secondary60
health care”.61
62
Much effort is placed on minimizing hospital delays [5,10-12]. A recent study on hospital delays in a sample of more63
than 50,000 HNC patients showed that delays from diagnosis to the initiation of curative treatment independently64
affected survival [13]. In addition, a meta-analysis concluded that with each month without treatment, the relative risk65
of death was increased by 1.16 [14].66
67
Delays may occur before patients seek medical care. Patient-related delays in the management of HNC as well as the68
underlying causes for these remain relatively unknown. A review of oral cancer showed that patient-related delay69
represents the most important factor influencing delay before treatment [15]. Socioeconomic factors and behavioral70
tendencies, such as the heavy use of alcohol, appear to associate with delay [16-18]. In addition, tumor site, the71
presence of symptoms and the heterogeneity and duration of symptoms before seeking medical care all influence delays72
3[19-21]. Thus, patients with mild symptoms or no perception of malignancy may seek medical attention later and may73
present with advanced disease [22,23]. Investigating the underlying causes for delay provides a possibility to discover74
means to shorten these delays. It seems reasonable to assume that any effort to decrease patient and treatment delays75
will improve cancer diagnosis at an earlier stage, thereby resulting in a better prognosis.76
77
In this study, we examined the lengths and causes for delays before referral to ENT department, that is, patient and PHC78
delays – in a one-year cohort of all new, consecutive HNC patients treated at our institution.79
80
Patients and methods81
We included all new adult HNC patients, but not those with thyroid cancer, treated at the Department of82
Otorhinolaryngology – Head and Neck Surgery at the Helsinki University Hospital over a one-year period (January 14,83
2015 through January 14, 2016). Our tertiary care center is the main specialist-care HNC center in Southern Finland84
with a referral area of 1.9 million inhabitants. To collect our data, we used a patient questionnaire and hospital records.85
In addition, we did not include patients with a previous HNC and patients incapable of understanding or completing the86
questionnaire (due to, for example, dementia). The self-administered questionnaire was distributed after the cancer87
diagnosis before definitive treatment or in case patient did not return the questionnaire during outpatient clinic88
appointment, sent by mail. It consisted of questions with pre-established set of choices on symptoms, the time of89
appearance of the initial symptom or sign, the time of first contact with a health care provider, the time of the first visit90
with a GP (or a dentist, a private otorhinolaryngologist, a hospital emergency department), the number of health care91
visits before referral to the ENT department and the patient’s perception whether his or her disease was considered as92
benign or possibly malignant. The Research Ethics Board at the Hospital District of Helsinki and Uusimaa approved the93
study design (record number: 398/13/03/02/15) and an institutional permission was granted to complete this study. All94
patients who participated in the study signed a written consent form.95
96
Data from hospital records included patient and tumor characteristics. Patient-related factors consisted of patient age,97
sex, history of smoking, the use of alcohol, education, employment and the place of residence (Table 1). We used98
commonly applied dose limits to measure the excessive use of alcohol (15 or more drinks per week for men and 8 or99
4more drinks per week for women) [24]. Tumor sites were documented according to ICD-10 classification codes, while100
TNM classification adhered to the seventh edition of the UICC cancer staging manual [25]. For our analysis, we101
grouped tumor sites as follows: oral cavity, oropharynx, hypopharynx, nasopharynx, larynx (differentiating glottic,102
supraglottic, subglottic and transglottic subsites), nose and paranasal sinuses, major salivary glands and unknown103
primary. In addition, tumors were divided into three groups based on histological types: squamous cell carcinomas104
(SCC) and its variants, salivary gland carcinomas and others. Table 2 summarizes the tumor-related characteristics.105
106
We also used the following time intervals in our analysis: 1. Patient delay represents the time period from the107
appearance of the first symptom to the initial contact with a health care provider; 2. PHC delay represents the time108
period from the patient´s first contact with a health care provider to receiving the referral to specialist-care treatment109
(Figure 1). For this study, we used the term ‘total delay before referral to specialist-care Department of110
Otorhinolaryngology – Head and Neck Surgery (ENT Department)’ (TD), which included both patient and PHC delays.111
We double-checked the delay data from hospital records which are based on the interview at the initial visit to our ENT112
Department, where the doctor typically asks about the duration of symptoms. If there was a major difference in delay113
times between these two sources of information, we used the information found in hospital records as it is documented114
before the cancer diagnosis. This source of information was preferred to better avoid recall bias and patients’ potential115
fear of being judged by doctors for postponing their search for medical care, when the nature of the disease is revealed.116
In most of the cases the delay information received from questionnaires were in line with the data found in hospital117
records. In our analysis, we compared these three delay parameters to patient symptoms as well as to patient and tumor118
characteristics. PHC delay was analyzed separately according to the initial place of visit: GP, private119
otorhinolaryngologist, dentist or hospital emergency department.120
121
We used SPSS version 24 (SPSS, Inc., Chicago, IL, USA) for all statistical analyses. The distributions of delays skewed122
to the right, since most patients reported shorter delays than the average. Therefore, we employed nonparametric tests in123
our statistical analysis. When analyzing the delay in two independent groups, we employed the Mann-Whitney U-test;124
when analyzing more than two independent groups, we employed the Kruskall-Wallis test. The post-hoc p values for125
the Kruskall-Wallis test included a Bonferroni correction. Patient delays, PHC delays and TD are reported using the126
median values. Multivariable linear model was employed to adjust for other factors and to examine which factors127
independently associated with delay. As the distribution of delay data was positively skewed, natural log-transformation128
5was performed for delay variables. Factors with a p-value less than 0.2 in univariate analysis were included in the129
multivariable analysis. The extent of the disease was adjusted using stage instead of T class and/or N class to avoid130
collinearity problems. Tumor site was not used in multivariable models because of high correlation with stage. Specific131
symptoms were not included in the multivariable analysis as they are considered to result from the disease. Results of132
multivariable analysis are expressed using adjusted geometric means and their 95% confidence intervals. We considered133
p < .05 statistically significant.134
135
Results136
During the study period, 202 new HNC patients were referred to our department. From these, 6 patients refused to137
participate in the study, 22 patients did not return the questionnaire and 32 patients did not fulfil the inclusion criteria138
for several reasons. Patients were not included because they were incapable of understanding the questions due to139
dementia (n = 12), they were unable to speak Finnish or Swedish (n = 8), they had a previously diagnosed HNC (n = 6),140
they presented in a poor overall condition (n = 3) or they were incapable of completing the questionnaire due to other141
factors (n = 3). The remaining 142 patients completed the questionnaire and formed our study cohort.142
143
Among the 142 patients in our study, 104 (73%) were men and 38 (27%) were women with a mean age of 62 years144
(range, 21--86). Table 1 summarizes other patient-related factors. SCC and its variants comprised most of the tumors (n145
= 117; 82%), and the most common site was the oropharynx (n = 47; 33%). Table 2 shows all of the tumor-related146
factors. The majority of patients (n = 138; 97%) were treated with a curative intent, while four (3%) received palliative147
care.148
149
Pain represented the most common symptom reported affecting 51% of all patients. The most important main initial150
symptom reported by patients leading them to seek medical care was a lump on the neck (n = 45; 31%). Table 3151
summarizes patient-reported symptoms and their relation to delays.152
153
6The median patient delay was 35 days (mean, 128 days; range, 0 days--8.9 years; Figure 2). The patient delay was less154
than three months for 72.5% of patients. We found no significant correlation between patient characteristics and patient155
delay (Table 1). Age did not have a statistically significant correlation with patient delay (rs=0.031, p=0.715), primary156
health care delay (rs=-0.029, p=0.733), or TD (rs=0.031, p=0.713). However, patient delay was significantly associated157
with tumor site and nodal disease (Table 2), and with specific symptoms: hoarseness and difficulties breathing resulted158
in longer delays, whereas patients reporting a lump on the neck associated with significantly shorter delays (Table 3).159
160
The median PHC delay was 20 days (mean, 98 days; range, 0 days--14 years) and 27% of patients sought medical161
advice within a week after noticing symptoms. Overall, the PHC delay was less than 3 months in 78.9% of patients. The162
initial place of visit significantly impacted the PHC delay (p = .016). More specifically, patients who contacted a private163
otorhinolaryngologist (n = 21) had a significantly shorter PHC delay before referral to ENT department than those who164
contacted a GP (n = 97; p = .027). Among all patients, 97 (73%) initially contacted a GP, 21 (16%) a private165
otorhinolaryngologist, 8 (6%) a hospital emergency department and 7 (5%) a dentist. Among patients grouped by initial166
contact point, the median PHC delays were 21, 4, 17 and 24 days, respectively. The remaining 9 patients did not report167
these data. Overall, TD, which included both patient and PHC delays, was less than 3 months in 53.5% of patients.168
169
At the initial visit, 74 (55%) patients were referred directly to our ENT department, 29 (21%) received treatment or170
further examinations through a scheduled new appointment, 11 (8%) received treatment without any further171
appointments and 21 (16%) received no treatment or follow-up visits. The remaining 7 patients did not report these172
data. Patients referred for specialist treatment or who received a new appointment at the initial visit had a significantly173
shorter median PHC delay than patients who received no follow-up visits (14 days vs. 102 days; p < .001). On average,174
patients had 2 (mean 2.4) visits to a physician before a referral for specialist treatment. The number of visits175
significantly correlated with the PHC delay (p < .001). In addition, 55 (39%) patients had 1 visit, 33 (23%) 2 visits, 17176
(12%) 3 visits, 14 (10%) 4 visits and 10 (7%) 5 or more visits. The remaining 13 patients did not report these data. The177
median PHC delays in these groups of patients were 11, 20, 35, 50 and 175 days, respectively. Regarding patients’178
perception of the GPs expression of the disease, 55 (39%) patients reported that the disease was considered benign by179
the physician at the initial visit, 29 (21%) were told they had a possible malignancy and 56 (40%) expressed no opinion.180
Two patients did not report these data.181
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Multivariable analysis (Table 4) revealed that patient delay and total delay in stage 0-II disease were significantly183
longer than in stage III-IV disease. Patients, who contacted a private otorhinolaryngologist had significantly shorter184
PHC delay than patients who contacted a GP. PHC delay and TD were shorter among patients, who had 1-3 visits185
before referral to ENT Department than those who had 4 visits or more.186
187
Discussion188
We assessed the length of and causes for patient and primary health care (PHC) delays in the management of head and189
neck cancer (HNC). To date, we know of no similar studies on more common malignancies, such as lung, prostate and190
breast cancer. Some previous studies on HNC have focused on a single or a few cancer sites [21,26]. Furthermore, some191
studies have divided patients into delay and non-delay groups with no clear criteria, but did not analyze delay as a192
continuous variable [16,21,27]. This study, however, addresses delays among all HNC sites, and includes a large variety193
of relevant patient- and tumor-related factors.194
195
In our patient population consisting of all consecutive new HNC cases, patients´ delay in seeking medical care196
associated with specific symptoms, signs and tumor characteristics, whereas none of the patient characteristics appeared197
to associate with delays. About one-fourth of patients sought medical care within a week. The majority of patients198
(73%) sought medical care within 3 months after initially noticing symptoms. The mean patient delay in our study (4.3199
months) was in agreement with a review on oral cancer that reported a mean patient delay of 3.5 to 5.4 months [15].200
However, using the mean rather than the median delay can be misleading, since delays are not normally distributed. In201
our cohort, the majority (79%) of patients had a shorter delay than the mean, while a few patients reported very long202
delays of more than a year (Table 5).203
204
The most important symptoms or signs affecting patient delay included a lump on the neck, hoarseness and difficulties205
breathing. A lump on the neck, typically caused by lymphatic metastasis, encouraged patients to seek medical care206
sooner than other symptoms. Thus, it appears that a lump on the neck presenting as a palpable tumor mass in a visible207
location is a symptom that raises patient awareness of potentially malignant disease, a conclusion supported by other208
studies [6,26]. Similarly, the presence of lymphatic metastases (N+ class) correlated significantly with shorter median209
8patient delay (28 vs. 57 days) and total delay before referral to ENT department (TD) (48 vs. 116 days) [23]. Avoiding210
disease progression due to delays is of utmost importance to improving the possibility for prompt curative treatment for211
locally advanced disease [20]. By contrast, hoarseness correlated with longer patient delay. Hoarseness represents a212
common symptom in numerous benign conditions and is a well-known adverse effect of smoking that often appears213
gradually. In glottic cancer, hoarseness might be the only symptom. Hence, patients may easily misjudge the nature of214
their symptom and postpone seeking medical care. In fact, physicians usually assessed hoarseness correctly as a sign of215
malignancy and, therefore, PHC delay was short. Difficulties in breathing also resulted in a longer patient delay and216
longer TD. This finding might seem counterintuitive since one might assume that difficulty breathing would lead a217
patient to seek medical care immediately. After reviewing the data, it seemed that some patients reporting breathing218
problems in fact suffered from nasal obstruction. The presence of pain or its intensity had no effect on delays among our219
study population, an observation similarly reported by Amir et al. [19]. Even if patients required painkillers daily, their220
delay in seeking medical care was not shorter. It seems that currently available pain medications adequately relieve221
pain, thus patients do not suspect cancer. Contrary to our findings, Väisänen et al. [23] found that patients experiencing222
pain reported shorter patient delay.223
224
In addition, we found that none of the sociodemographic factors (age, sex, education, employment, place of residence)225
affected delay times, a finding consistent with other studies [6,19,20,26,28]. In our cohort, excessive alcohol226
consumption did not correlate with patient delay since both current and previous heavy drinkers exhibited similar delays227
compared to moderate drinkers and those who reported complete abstinence. Based on our study, we may only228
speculate the possible reasons why alcohol use may alter medical care seeking behavior. Other studies found an229
association between excessive alcohol consumption and longer patient delay [16,17]. Our study also revealed no230
correlation between tobacco smoking and patient delay. In two other studies, heavy smokers had generally shorter231
patient delay than light smokers [16,20]. Brouha et al. [16] suggest that this finding might be explained by the fact that232
heavy smokers acknowledge their increased risk for HNC and are more aware of any possible signs and symptoms of233
cancer. Yet, Väisänen et al. [23] reported that almost 50% of patients who smoke remained oblivious to this risk.234
Furthermore, we found no impact from patient employment on patient delay. In the literature, findings regarding the235
effect of socioeconomic status on patient delay vary. Some researchers reported that a lower socioeconomic status leads236
to longer patient delays [28,29], although a study from Great Britain did not support this hypothesis [20]. Similar to237
findings from Great Britain, however, the Finnish national public health care system allows patients to seek medical238
9care regardless of income, which may explain these differences across studies [20,28,29]. In our cohort, educational239
level and delays were not correlated, a finding consistent with Noonan et al. [28]. Patients’ psychological and240
psychosocial factors influence health behavior but for practical reasons they were not examined in this study [30,31].241
242
Tumor characteristics are crucial. Often, the tumor site, size, invasion to surrounding tissues and possible metastases243
cause diverse symptoms and eventually lead a patient to seek medical care. In this study, tumor site significantly244
correlated with patient delay and TD. The most notable difference was found for laryngeal cancers. Specifically,245
patients with supraglottic cancer had a median patient delay of 14 days compared to glottic cancer with a median delay246
of 133 days. Supraglottic tumors are often larger before they cause notable symptoms [21]. Blocked nose is a common247
symptom in the general population and thus cause indifference about this symptom. This might explain long delays for248
patients with tumors of the nose and paranasal sinuses. In the literature, the relationship between cancer site and patient249
delay vary greatly. Some studies reported a correlation between cancer site and patient delay [20,21], while others did250
not [6,19,23,26]. Patients with a salivary gland carcinoma, which tends to grow slowly, reported considerably longer251
PHC delay in our cohort than those with SCC. We found no correlation between T class and patient delay, a finding252
consistent with other studies [19,23,26]. At some sites, tumors can become fairly large before causing any notable253
symptoms, while the severity and emergence of symptoms vary. A positive N class tumor correlated with shorter patient254
delay and TD, which represented the primary cause of the correlation between more advanced disease stage and a255
shorter delay. The association between the stage of the disease and patient delay has been extensively studied with256
varying findings [6,10,21,23,26,27]. Patients may also experience various symptoms and the intensity of symptoms in a257
different way, which might affect the latency to seek for medical care [8].258
259
The type of first contact with medical care patients reported played a crucial role in their referral to specialist care. A260
visit to a private otorhinolaryngologist more often resulted in a referral to a specialist for treatment during the initial261
visit with a significantly shortened PHC delay than after visiting a GP. In addition, patients with a scheduled follow-up262
appointment had a significantly shorter median PHC delay (14 vs. 102 days), a finding consistent with a similar study263
[32]. Too often, a patient’s symptoms are interpreted as benign or treated as an infection (Table 6) [33]. Without264
information on the reference population that would represent patients with similar symptoms but who do not have265
cancer, it is hard to evaluate the reasons behind longer PHC delays among GPs. A GP might encounter only few new266
HNC patients during his/her career but thousands of patients with similar symptoms without any malignancy. This267
10
aspect would be of interest to study in the future. Given our findings, it seems appropriate to schedule at least a follow-268
up visit if the patient presents with symptoms potentially caused by HNC. If symptoms persist, the patient should be269
referred to a specialist without delay.270
271
Our study allowed for a structured and comprehensive data collection method. Yet, this also carries some limitations.272
As such, some patients were unable to complete the questionnaire for various reasons and were, therefore, not included273
in the study. Among these patients, palliative treatment was significantly more common (27% vs. 3%). At least some of274
these patients who did not fulfil the inclusion criteria would most likely have a longer delay due to their general health275
condition. Nevertheless, the cohort still included 70% of the annual HNC patients treated at our tertiary care center. The276
patient questionnaire was administrated after cancer diagnosis, which might have had an influence on the patient’s277
ability to accurately recall the onset of symptoms and lead to falsely reconstructed sequence of events as the outcome is278
known. In order to minimize recall bias, the delay data were double-checked from hospital records. Furthermore, the279
recall bias might vary between different symptoms, as some symptoms are more noticeable than others. In addition,280
patient reported data are always subjective, and, thus, open to interpretation. Furthermore, if a patient reported multiple281
symptoms, the sequence of the emergence of symptoms remained unclear. Our study also includes patients who282
experienced a delay of more than a year (Tables 5 and 6). This highlights the need for continuous education and283
awareness raising of disease and possible cancer-related symptoms among both the general population and health care284
personnel. We did not investigate the effect of p16/HPV status in this study, because it has role only in certain tumor285
sites, almost exclusively in the oropharynx. Furthermore, the number of patients with some tumor sites remained286
limited. Therefore, our analysis of delays in patients presenting with tumors at different subsites calls for further study.287
288
In conclusion, we show that symptoms, tumor-related factors and decisions made during the first contact with health289
care providers influence delay before specialist consultation. The majority of patients seek medical care fairly early and290
exceptionally long delays were fairly rare. Raising awareness of HNC symptoms among general population and GPs is291
the way to get patients to curative treatment without long delay.292
293
Legends to the figures294
Figure 1. Definitions of delays as used in this study.295
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Figure 2. Patient delay chart (n = 142 patients). Eleven patients had a delay of over one year due to the wide time range296
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